Postoperative Low‐Molecular‐Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators
- 26 February 2009
- journal article
- research article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 32 (3) , 378-382
Abstract
Background: The perioperative management of patients receiving oral anticoagulation therapy (OAC) who undergo pacemaker (PM) and defibrillator (ICD) surgery remains controversial. Low‐molecular‐weight heparin (LMWH) is often used; however, wound hematoma is a common complication. Methods: At a single academic Canadian center, between July 2003 and June 2005, details of perioperative OAC bridging and the rate of wound hematoma requiring reoperation or interruption of OAC were reviewed for all patients receiving LMWH bridging for PM or ICD surgery. Results: A total of 148 PM/ICD patients underwent perioperative bridging with LMWH. A significant hematoma occurred in 23 patients, requiring reoperation in three patients. No patient died, developed infection, or stroke. The initial bridging regimen included LMWH (enoxaparin 1 mg/kg BID) given until evening prior to surgery, and reinitiated on postoperative day 3. In response to high rates of postoperative hematoma, subsequent protocols omitted the LMWH on the evening before surgery, all postoperative LMWH, or both. The use of LMWH the night before surgery had no effect on hematoma rates (12% vs 17%, P = 0.62); however, the use of any postoperative LMWH increased hematoma rates (23% vs 8%, P = 0.01). Hematoma rates were not increased in patients receiving acetylsalicylic acid (19% vs 16%, P = 0.62) or clopidogrel (25% vs 17%, P = 0.54). In a multivariate analysis, independent predictors of significant wound hematoma included postoperative LMWH (P = 0.001), a higher international normalized ratio on the day of surgery (P = 0.03), and male sex (P = 0.05). Conclusion: Elimination of postoperative LMWH was associated with a substantial reduction in hematoma rates following PM and ICD surgery.Keywords
This publication has 15 references indexed in Scilit:
- The Perioperative Management of Antithrombotic TherapyChest, 2008
- Pocket Hematoma After Pacemaker or Implantable Cardioverter Defibrillator SurgeryChest, 2004
- Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of WarfarinCirculation, 2004
- Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of WarfarinArchives of internal medicine (1960), 2004
- Pacemaker and Implantable Cardioverter Defibrillator Implantation Without Reversal of Warfarin TherapyPacing and Clinical Electrophysiology, 2004
- Management of Anticoagulation in Patients Who Require Invasive ProceduresSeminars in Vascular Medicine, 2003
- Implantation of Pacemakers and Implantable Cardioverter Defibrillators in Orally Anticoagulated PatientsPacing and Clinical Electrophysiology, 2003
- The management of surgical complications of pacemaker and implantable cardioverter-defibrillatorsCurrent Opinion in Cardiology, 2001
- Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular CausesNew England Journal of Medicine, 2000
- Design and Results of the Antiarrhythmics vs Implantable Defibrillators (AVID) RegistryCirculation, 1999